Invesco
KYMR icon

Invesco’s Kymera Therapeutics KYMR Stock Holding History

Invesco’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.97M Sell
60,813
-49,602
-45% -$4.26M ﹤0.01% 2088
2026
Q1 		$9.2M Sell
110,415
-6,332
-5% -$501K ﹤0.01% 1877
2025
Q4 		$9.08M Buy
116,747
+36,940
+46% +$2.49M ﹤0.01% 1907
2025
Q3 		$4.52M Buy
79,807
+31,923
+67% +$1.44M ﹤0.01% 2274
2025
Q2 		$2.09M Buy
47,884
+5,809
+14% +$200K ﹤0.01% 2563
2025
Q1 		$1.15M Buy
42,075
+11,343
+37% +$413K ﹤0.01% 2774
2024
Q4 		$1.24M Sell
30,732
-133,187
-81% -$6.02M ﹤0.01% 2829
2024
Q3 		$7.76M Buy
163,919
+134,085
+449% +$5.92M ﹤0.01% 1979
2024
Q2 		$891K Sell
29,834
-83,533
-74% -$2.89M ﹤0.01% 2992
2024
Q1 		$4.56M Buy
113,367
+85,278
+304% +$3.05M ﹤0.01% 2294
2023
Q4 		$715K Sell
28,089
-8,538
-23% -$153K ﹤0.01% 3040
2023
Q3 		$509K Buy
36,627
+6,197
+20% +$125K ﹤0.01% 3196
2023
Q2 		$700K Sell
30,430
-159,056
-84% -$4.56M ﹤0.01% 3068
2023
Q1 		$5.61M Buy
189,486
+175,993
+1,304% +$5.68M ﹤0.01% 2163
2022
Q4 		$337K Sell
13,493
-3
-0% -$80 ﹤0.01% 3458
2022
Q3 		$294K Sell
13,496
-67
-0.5% -$1.77K ﹤0.01% 3526
2022
Q2 		$267K Sell
13,563
-1,808
-12% -$42.2K ﹤0.01% 3616
2022
Q1 		$650K Buy
15,371
+146
+1% +$6.17K ﹤0.01% 3271
2021
Q4 		$967K Sell
15,225
-171
-1% -$9.96K ﹤0.01% 3077
2021
Q3 		$904K Buy
15,396
+6,132
+66% +$356K ﹤0.01% 3152
2021
Q2 		$450K Buy
+9,264
New +$402K ﹤0.01% 3462

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Invesco's KYMR Position: Q2 2026 in Review

Invesco reduced its Kymera Therapeutics (KYMR) stake by 45% in Q2 2026, selling an estimated $4.26M and leaving 60,813 shares worth $6.97M. The position accounts for ﹤0.01% of the portfolio, ranked #2088.

Invesco first reported a position in KYMR in Q2 2021 and has held it in 21 quarters since. The position peaked at $9.2M in Q1 2026. 277 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Invesco held 60,813 shares of Kymera Therapeutics worth $6.97M as of Q2 2026.
  • Invesco sold 49,602 Kymera Therapeutics shares in Q2 2026, an estimated $4.26M.
  • Kymera Therapeutics made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #2088 holding.
  • Invesco first reported a position in Kymera Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • Invesco's Kymera Therapeutics position peaked at $9.2M in Q1 2026.
  • 277 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.